Prof. Dr. Gerold Schuler

Medizinische Fakultät Lehrstuhl für Haut- und Geschlechtskrankheiten

Old Age, nodular Melanoma, Tumor Thickness and Ulceration are Risk Factors for regional and systemic Metastases in Melanoma Patients after negative Sentinel Node Biopsy (2017) Erdmann M, Dominik S, Göhl J, Grützmann R, Schuler G, Schellerer V Conference contribution Human lymphoid organ dendritic cell identity is predominantly dictated by ontogeny, not tissue microenvironment (2017) Heidkamp GF, Sander J, Lehmann CHK, Heger L, Eissing N, Baranska A, Lühr J, et al. Conference contribution CAR/TCR-transfected gamma/delta T cells for immunotherapy of melanoma (2017) Harrer DC, Simon B, Fujii S, Shimizu K, Uslu U, Schoch L, Schuler G, et al. Conference contribution A systems biology approach to characterize the function of miRNAs in dendritic cell-mediated immunogenicity and therapeutic cancer vaccination (2017) Lai X, Dreyer F, Jaitly T, Gerer KF, Schuler G, Dörrie J, Schaft N, Vera J Conference contribution BRAF and MEK inhibitors influence human immune cell phenotype and function (2017) Hoyer S, Eberlein V, Babalija L, Gerer KF, Walter L, Schuler G, Schaft N, et al. Conference contribution The simultaneous siRNA-mediated downregulation of inhibitory receptors to improve CAR-T cell immunotherapy of melanoma (2017) Simon B, Harrer D, Weide B, Schuler G, Schuler-Thurner B, Dörrie J, Schaft N, Uslu U Conference contribution RNA-transfection of gamma/delta T cells with a chimeric antigen receptor or an alpha/ss T-cell receptor: a safer alternative to genetically engineered alpha/ss T cells for the immunotherapy of melanoma (2017) Harrer D, Simon B, Fujii SI, Kanako S, Uslu U, Schuler G, Gerer KF, et al. Conference contribution Ex vivo expanded NK cells up-regulate natural cytotoxicity receptors able to mediate autologous melanoma cell killing (2017) Roessner S, Gross S, Karg M, Hamann A, Campana D, Schuler-Thurner B, Bosch JJ, et al. Conference contribution Characterization and Expansion of Autologous GMP-ready Regulatory T Cells for TREG-based Cell Therapy in Patients with Ulcerative Colitis (2017) Voskens CJ, Fischer A, Roessner S, Lorenz C, Hirschmann S, Atreya R, Neufert C, et al. Journal article Good Manufacturing Practice-Compliant Production and Lot-Release ofEx VivoExpanded Regulatory T Cells As Basis for Treatment of Patients with Autoimmune and Inflammatory Disorders (2017) Wiesinger M, Stoica D, Roessner S, Lorenz C, Fischer A, Atreya R, Neufert C, et al. Journal article